Success Stories: EB1A Approval for a Research Fellow in the field of Immunology in 2.5 months
Client’s Testimonial:
Thank you so much for your help, I am highly satisfied with your service! I appreciate your help!
On October 9, 2013 we received another EB1-A (Alien of Extraordinary Ability) Approval for a Research Fellow in the field of Immunology(Approval Notice)
General Field: Immunology
Position at the Time of Case Filing: Research Scientist and Instructor
National Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Connecticut
Approval Notice Date: October 9, 2013
Processing Time: 2 ½ months
Case Summary:
This case was approved in 2.5 months without the request of premium processing. Cases filed by North America Immigration Law Group – WeGreened.com have a shorter approved time than the average USCIS processing because we barely received RFE (Request for Evidence) and we presented the cases convincingly and clearly for the immigration officer to grant an approval within a short time.
The client in this case was a research scientist and instructor from China in the field of immunology. His work had focused primarily on designing studies regarding 3rd generation designer T cells in battle with cancerous cells. This client also tests mechanisms in order to find an improvement for these T cells, along with their abilities to fight stage tumors. His work resulted in 17 peer-reviewed scholarly publications and 3 conference presentations appearing in leading journals and conference proceedings. At the time that his case was filed, his publications had accumulated at least 220 citations, showing that his work is of high importance throughout his field around the world. With his experience in immunology, molecular biology, cellular biology, and biochemistry, it is of no surprise that he holds a spot in The American Association of Immunologists. In addition, this client was a reviewer for many well-known journals within his related fields. Of his accomplishments, one of his independent recommenders remarked, “[Client] has already greatly assisted in the progress in molecular oncology, and I believe he will continue to contribute in the treatment of advanced stage cancer patients with disseminated cancer cells. This is especially important work as these particular patients are no treatable through currently available methods. [Client]’s work represents the final line of defense for patients with advanced stage cancers by improving their chances of survival.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States in order to continue his immunology research, and that his continued research would noticeably benefit the United States. With the proof and documentation provided, the case of this client was approved within 2 ½ months.